Literature DB >> 12850167

Visceral leishmaniasis. Persistence of parasites in lymph nodes after clinical cure.

J Dereure1, H Duong Thanh, T Lavabre-Bertrand, G Cartron, F Bastides, D Richard-Lenoble, J P Dedet.   

Abstract

Visceral leishmaniasis (VL) is generally associated with severe immunodeficiency (AIDS; renal, liver, and heart transplantations; haemopoietic malignancies). More rarely it can be related to an immunotolerence status such as pregnancy. Various observations report the development of leishmaniasis several months or even years after exposure to the parasite. Relapses occur rarely in patients not known to be immunocompromised, but are common after incomplete treatment. They are frequent in patients with Leishmania/HIV co-infection. Asymptomatic phases and relapses suggest that parasite can exist in the tissues for a long time before and/or after clinical onset of the disease. The mechanisms of onset of clinical leishmaniasis following exposure and infestation are highly relevant to understanding the pathology of the disease. The survival of Leishmania parasite between infection and disease or after cure is a very important issue for clinicians and epidemiologists. We describe two cases of VL occurring in a patient with lymphoma and in a pregnant woman. In both cases, parasites remained present in the lymph nodes after clinical cure.

Entities:  

Mesh:

Year:  2003        PMID: 12850167     DOI: 10.1016/s0163-4453(03)00002-1

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  13 in total

1.  Rare association of Visceral leishmaniasis with Hodgkin's disease: A case report.

Authors:  Rakshit Kumar; Mradul K Daga; Nitish L Kamble; Arpit Sothwal; Tejinder Singh; Hemanta K Nayak; Nishant Raizada
Journal:  Infect Agent Cancer       Date:  2011-10-20       Impact factor: 2.965

2.  Molecular detection of infection homogeneity and impact of miltefosine treatment in a Syrian golden hamster model of Leishmania donovani and L. infantum visceral leishmaniasis.

Authors:  Eline Eberhardt; Annelies Mondelaers; Sarah Hendrickx; Magali Van den Kerkhof; Louis Maes; Guy Caljon
Journal:  Parasitol Res       Date:  2016-07-13       Impact factor: 2.289

Review 3.  Leishmaniasis.

Authors:  T V Piscopo; A C Mallia
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

Review 4.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 5.  Leishmaniasis.

Authors:  Tonio V Piscopo; Charles Mallia Azzopardi
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

6.  Comparative immune study on cutaneous leishmaniasis patients with single and multiple sores.

Authors:  Ban Noori Al-Qadhi; Israa Salim Musa; Yassir Mustafa Kamal Al-Mulla Hummadi
Journal:  J Parasit Dis       Date:  2013-11-21

Review 7.  Leishmaniasis-HIV coinfection: current challenges.

Authors:  José Angelo Lauletta Lindoso; Mirella Alves Cunha; Igor Thiago Queiroz; Carlos Henrique Valente Moreira
Journal:  HIV AIDS (Auckl)       Date:  2016-10-07

8.  Visceral leishmaniasis during pregnancy: A rare case report from Greece.

Authors:  Periklis Panagopoulos; Vasileios Mitsopoulos; Antonios Papadopoulos; Spyridoula Theodorou; Chrysoula Christodoulaki; Kyriakos Aloupogiannis; Nikolaos Papantoniou
Journal:  PLoS Negl Trop Dis       Date:  2017-02-16

9.  Comparison of Three In-House Real PCR Assays Targeting Kinetoplast DNA, the Small Subunit Ribosomal RNA Gene and the Glucose-6-Phosphate Isomerase Gene for the Detection of Leishmania spp. in Human Serum.

Authors:  Konstantin Tanida; Carsten Balczun; Andreas Hahn; Alexandra Veit; Beatrice Nickel; Sven Poppert; Patrick Leander Scheid; Ralf Matthias Hagen; Hagen Frickmann; Ulrike Loderstädt; Egbert Tannich
Journal:  Pathogens       Date:  2021-06-30

10.  Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis.

Authors:  Rahul Shivahare; Preeti Vishwakarma; Naveen Parmar; Pawan Kumar Yadav; Wahajul Haq; Mrigank Srivastava; Suman Gupta; Susanta Kar
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.